Profile: Montvale Technologies Inc (IVVI.PK)
Montvale Technologies, Inc., formerly Ivivi Technologies, Inc., incorporated on March 9, 1989, is an early stage medical technology company focusing on designing, developing and commercializing electrotherapeutic technologies. The Company has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The Company is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The Company is developing technology for other therapeutic medical markets.
The SofPulse M-10 utilizes a box-shaped signal generator that weighs approximately seven pounds. The signal generator delivers tPEMF signals through a lightweight and conformable applicator that ranges in diameter. The SofPulse M-10 is marketed for sale, as well as rented to the chronic wound care markets, particularly for use in long-term acute care hospitals, as well as in long-term care nursing facilities, rehabilitation hospitals, acute care hospitals and facilities and home health care systems.
The Roma(3) utilizes a disk-shaped signal generator that is approximately nine inches in diameter and weighs approximately two pounds. The signal generator delivers the tPEMF signals simultaneously through up to three lightweight and conformable devices that range in diameter, allowing multiple treatments on the same patient. The signal generator contains a programmable microprocessor that can automatically activate and deactivate the Roma(3) for ongoing, unattended treatment. The devices utilized by the Roma(3) are intended for single-patient use and are disposable. The Roma(3) is primarily marketed as a rental product to the chronic wound care markets, particularly for use in long-term acute care hospitals, as well as in long-term care nursing facilities, rehabilitation hospitals, acute care hospitals and facilities and home health care systems.
The Torino II is a battery powered, disposable single unit consisting of both the signal generator and applicator for ease of use. The devices that are incorporated into the Torino II are also lightweight and conformable and come in varying sizes, depending on the application. The signal generator used in the Torino II is also pre-programmed to provide therapy at optimal intervals throughout the course of therapy.
The Company competes with Diapulse Corporation of America, Inc., Regenesis Biomedical, BioElectronics Corporation and Kinetics Concepts, Inc.
Montvale Technologies Inc
224s Pegasus Ave
NORTHVALE NJ 07647-1904